Using their years of experience in product development, assay automation, and clinical trial patient testing, IST offers a suite of unique, proven, functional, immune monitoring assays and particle characterization as testing services for pharma and biotech companies, as well as trial organizations, involved in immune-based drug, vaccine and biologics drug discovery and development. IST assays are fully 
standardized and automated, and have undergone rigorous validation and verification, with data to support the accuracy, precision, inter- and intra-assay verification, specificity, and limit of detection.
At IST’s GLP-compliant immune monitoring, cell mediated immunity, and particle characterization laboratories, the automated assays for vaccine and/or biologics development are performed within tight specifications yielding precise and accurate findings with a fast turnaround time. This helps IST to ensure that the data collected on clinical trial patient samples are of the highest quality to support pharma investigations. Additionally, these types of assays have been used successfully to follow drug candidates through all phases of clinical trials over more than 36 months, and may emerge as a companion diagnostic for therapeutic stratification or monitoring.
